Position in MRNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$667,952,718
+$237,612,564 QoQ
Shares Held
9,538,094
+12.6% QoQ
Ownership
2.39%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#9
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. MRNA ranks #5 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
This page
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in MRNA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $667,952,718 | 9,538,094 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $430,340,154 | 8,471,263 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $261,597,407 | 8,870,716 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $257,324,446 | 9,962,232 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $223,576,606 | 8,103,538 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $210,878,774 | 7,438,405 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $176,619,274 | 4,247,698 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $234,512,409 | 3,509,089 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $594,524,243 | 5,006,520 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $585,436,900 | 5,493,965 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $436,496,783 | 4,389,108 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $548,677,919 | 5,312,014 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $706,775,821 | 5,817,085 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $760,308,993 | 4,950,573 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $752,132,337 | 4,187,353 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $415,893,404 | 3,517,069 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $497,335,411 | 3,481,522 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $501,415,092 | 2,910,804 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,229,480,602 | 4,840,856 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,178,841,394 | 5,661,387 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,743,903,360 | 7,421,497 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $1,076,774,086 | 8,222,788 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $605,412,422 | 5,795,084 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $356,112,128 | 5,033,387 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $409,924,664 | 6,384,125 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $164,276,556 | 5,485,027 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||